Effect of quercetin on atherosclerosis risk factors, inflammation biomarkers and oxidative stress, based on the apolipoprotein E (APOE) genotype.
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2015
At a glance
- Drugs Quercetin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Dec 2015 New trial record